ALKBH5 and breast cancer: For example, the overexpression of YTHDF1 is related to poor prognosis in patients with liver cancer [11]; downregulation of ALKBH5 in MDA-MB-231 human breast cancer cells can lead to a decrease in the number of breast cancer stem cells, resulting in a significant reduction in tumorigenic capacity [12].